NPI: 1548250582 · SPARKS, NV 89434 · General Acute Care Hospital · NPI assigned 10/21/2005
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR VP) |
| NPI Enumeration Date | 10/21/2005 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 43,630 | $574K |
| 2019 | 93,535 | $1.41M |
| 2020 | 67,886 | $1.11M |
| 2021 | 74,996 | $1.10M |
| 2022 | 68,763 | $1.18M |
| 2023 | 66,310 | $1.25M |
| 2024 | 46,914 | $1.01M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17,040 | 13,820 | $1.44M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 15,019 | 12,952 | $1.21M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 18,455 | 15,535 | $904K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,897 | 3,211 | $821K |
| G0378 | Hospital observation service, per hour | 2,962 | 2,059 | $352K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,704 | 2,241 | $199K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5,740 | 1,847 | $175K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,960 | 4,479 | $159K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,042 | 839 | $158K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11,107 | 8,691 | $148K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4,161 | 1,641 | $125K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,798 | 1,551 | $121K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 656 | 512 | $120K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 489 | 329 | $115K |
| 80053 | Comprehensive metabolic panel | 24,833 | 18,883 | $81K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3,499 | 1,208 | $79K |
| 96375 | Therapeutic injection; each additional sequential IV push | 8,240 | 6,250 | $77K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4,348 | 3,399 | $75K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 29,901 | 22,365 | $67K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 6,878 | 5,461 | $65K |
| 96361 | Intravenous infusion, hydration; each additional hour | 7,536 | 5,765 | $60K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,531 | 1,923 | $56K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,712 | 2,233 | $55K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,063 | 899 | $49K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 7,554 | 5,536 | $48K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 14,631 | 10,955 | $46K |
| 71045 | Radiologic examination, chest; single view | 9,035 | 7,413 | $44K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,589 | 2,067 | $40K |
| 71046 | Radiologic examination, chest; 2 views | 3,565 | 2,982 | $35K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,031 | 431 | $30K |
| 84484 | 11,123 | 6,559 | $29K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,885 | 1,574 | $28K |
| 36415 | Collection of venous blood by venipuncture | 35,454 | 25,517 | $27K |
| 72125 | Computed tomography, cervical spine; without contrast material | 213 | 187 | $25K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,133 | 1,040 | $24K |
| 0450 | Emergency room services | 504 | 452 | $23K |
| 94060 | 599 | 553 | $21K | |
| 83690 | 9,753 | 7,840 | $21K | |
| 93971 | 373 | 314 | $19K | |
| 94726 | 593 | 548 | $19K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 7,528 | 5,836 | $18K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4,165 | 1,803 | $18K |
| 94729 | 594 | 549 | $16K | |
| 84703 | 5,436 | 4,577 | $15K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 488 | 328 | $14K |
| 83880 | 1,823 | 1,447 | $14K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 944 | 771 | $14K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 939 | 767 | $12K |
| 96376 | 2,069 | 1,370 | $11K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 186 | 149 | $11K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,898 | 1,743 | $11K |
| 73630 | 796 | 679 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,415 | 3,651 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,246 | 1,895 | $10K |
| 81001 | 10,137 | 8,282 | $10K | |
| 83605 | 3,478 | 2,431 | $10K | |
| 73610 | 605 | 533 | $9K | |
| 97162 | 238 | 214 | $9K | |
| 87430 | 1,653 | 1,415 | $8K | |
| 97161 | 263 | 241 | $8K | |
| 73564 | 474 | 423 | $8K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 8,621 | 6,966 | $8K |
| 81025 | 3,770 | 3,200 | $8K | |
| 87070 | 2,717 | 2,267 | $8K | |
| 93017 | 746 | 542 | $7K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 415 | 388 | $7K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 4,068 | 2,772 | $7K |
| 87040 | 2,382 | 1,050 | $7K | |
| J2785 | Injection, regadenoson, 0.1 mg | 275 | 172 | $7K |
| 72100 | 806 | 614 | $6K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,910 | 1,459 | $6K |
| 73130 | 402 | 357 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 943 | 720 | $6K |
| 73030 | 316 | 266 | $6K | |
| 80061 | Lipid panel | 1,645 | 1,362 | $6K |
| 87186 | 2,316 | 1,860 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 44 | 42 | $5K |
| 85379 | 1,499 | 1,243 | $5K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,710 | 4,757 | $5K |
| 90715 | 259 | 221 | $5K | |
| 83735 | 2,689 | 1,957 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 351 | 301 | $4K |
| 85610 | 4,480 | 3,292 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,654 | 1,288 | $3K |
| 84702 | 645 | 515 | $3K | |
| 76830 | Ultrasound, transvaginal | 56 | 44 | $3K |
| 76801 | 57 | 49 | $3K | |
| 87077 | 1,357 | 1,087 | $3K | |
| 81003 | 4,867 | 4,045 | $3K | |
| 85730 | 2,542 | 1,929 | $3K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,242 | 1,452 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,264 | 1,050 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 8,906 | 6,848 | $2K |
| 84439 | 857 | 721 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,753 | 3,784 | $2K |
| 85027 | 1,185 | 969 | $2K | |
| 82962 | 6,222 | 2,259 | $2K | |
| 73110 | 100 | 87 | $2K | |
| 71250 | 22 | 17 | $2K | |
| 74018 | 184 | 158 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,889 | 1,970 | $2K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,349 | 1,809 | $2K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 12 | 12 | $2K |
| 74022 | 52 | 42 | $1K | |
| 87561 | 76 | 71 | $1K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 338 | 264 | $1K |
| 87899 | 319 | 247 | $1K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 668 | 511 | $1K |
| 86140 | 767 | 607 | $1K | |
| 87205 | 1,032 | 796 | $1K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1,696 | 207 | $829.16 |
| J2704 | Injection, propofol, 10 mg | 3,595 | 2,759 | $788.35 |
| 10060 | 12 | 12 | $710.42 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 5,917 | 4,223 | $704.21 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 501 | 263 | $664.31 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 12 | 12 | $628.46 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 956 | 748 | $603.94 |
| J1790 | Injection, droperidol, up to 5 mg | 109 | 85 | $598.51 |
| 86901 | 755 | 570 | $596.33 | |
| 86900 | 738 | 558 | $586.37 | |
| 85652 | 835 | 633 | $584.37 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 13 | 12 | $553.24 |
| 87210 | 333 | 269 | $521.10 | |
| J2060 | Injection, lorazepam, 2 mg | 1,106 | 802 | $439.79 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 119 | 97 | $438.56 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 2,473 | 1,807 | $368.95 |
| 82803 | 70 | 54 | $349.14 | |
| 80076 | 138 | 120 | $334.90 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,858 | 2,919 | $299.48 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 12 | 12 | $294.50 |
| 73502 | 13 | 12 | $278.79 | |
| 73090 | 16 | 13 | $204.38 | |
| 87420 | 35 | 29 | $200.81 | |
| G0008 | Administration of influenza virus vaccine | 33 | 30 | $139.20 |
| 97165 | 23 | 14 | $136.68 | |
| J1644 | Injection, heparin sodium, per 1000 units | 407 | 186 | $129.07 |
| J1630 | Injection, haloperidol, up to 5 mg | 90 | 64 | $127.56 |
| 72040 | 34 | 25 | $126.60 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 30 | 25 | $105.22 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 120 | 95 | $104.42 |
| 86850 | 102 | 75 | $83.40 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 243 | 196 | $79.02 |
| J8540 | Dexamethasone, oral, 0.25 mg | 52 | 44 | $76.57 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 500 | 429 | $66.02 |
| 90686 | 33 | 30 | $52.45 | |
| 82550 | 27 | 26 | $44.35 | |
| 82075 | 16 | 13 | $41.51 | |
| 84100 | 36 | 26 | $21.95 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 29 | 25 | $21.30 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 38 | 27 | $20.60 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 15 | 13 | $19.48 |
| 82272 | 18 | 14 | $19.43 | |
| 87081 | 16 | 14 | $9.15 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 47 | 45 | $1.64 |
| A9270 | Non-covered item or service | 12,113 | 2,168 | $0.47 |
| C1769 | Guide wire | 17 | 17 | $0.00 |
| 72020 | 129 | 96 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 17 | 13 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 291 | 197 | $0.00 |
| 0353U | 276 | 254 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 103 | 94 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 59 | 27 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 16 | 13 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 17 | 13 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 15 | 15 | $0.00 |